ImmunityBio
Tiffaney Burford, MBA, currently serves as the Director of the Oncology Program at ImmunityBio, Inc. With a strong background in clinical development, Tiffaney has held several key positions at Amgen, including Sr. Manager for Global Early Clinical Development and Global Clinical Trial Manager. Tiffaney also co-founded and served as CEO of C & C Burford. Previous experience includes a role as Contract Clinical Operations Lead at Biogen Idec and teaching as a lecturer at Boston University - Metropolitan College. Tiffaney holds a Bachelor's Degree in Chemistry from Mount Holyoke College and an MBA in Health Care Management from Regis University.
This person is not in the org chart
This person is not in any offices
ImmunityBio
4 followers
ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells.